Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1984 Apr;55:359–367. doi: 10.1289/ehp.8455359

Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.

R M Philpot, B R Smith
PMCID: PMC1568372  PMID: 6376107

Abstract

The lung metabolizes a wide variety of xenobiotics and, in the process, forms products that may be more or less toxic than the parent compound. The consequence of metabolism, activation or detoxication, is a function of the nature of the substrate and of the characteristics and concentrations of the enzymes involved. As a result, the biotransformation of xenobiotics can lead to their excretion or to the formation of reactive products that produce deleterious effects by binding covalently to tissue macromolecules. Among the enzymes that metabolize xenobiotics, those associated with the cytochrome P-450-dependent monooxygenase system are probably the most important. The route by which a given substrate is metabolized in a tissue or cell is, to a great extent, determined by the types and concentrations of cytochrome P-450 isozymes present. We are just beginning to understand the distribution of these enzymes in lung and to appreciate the species and cellular differences that exist.

Full text

PDF
359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. W., Boroujerdi M., Wilson A. G. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole. Cancer Res. 1981 Nov;41(11 Pt 1):4309–4315. [PubMed] [Google Scholar]
  2. Bend J. R., Hook G. E., Gram T. E. Characterization of lung microsomes as related to drug metabolism. Drug Metab Dispos. 1973 Jan-Feb;1(1):358–367. [PubMed] [Google Scholar]
  3. Boyd M. R. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. Crit Rev Toxicol. 1980 Aug;7(2):103–176. doi: 10.3109/10408448009037487. [DOI] [PubMed] [Google Scholar]
  4. Boyd M. R. Metabolic activation and lung toxicity: a basis for cell-selective pulmonary damage by foreign chemicals. Environ Health Perspect. 1984 Apr;55:47–51. doi: 10.1289/ehp.845547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boyland E., Chasseaud L. F. The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis. Adv Enzymol Relat Areas Mol Biol. 1969;32:173–219. doi: 10.1002/9780470122778.ch5. [DOI] [PubMed] [Google Scholar]
  6. Brodie B. B., Reid W. D., Cho A. K., Sipes G., Krishna G., Gillette J. R. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A. 1971 Jan;68(1):160–164. doi: 10.1073/pnas.68.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brookes P. Covalent interaction of carcinogens with DNA. Life Sci. 1975 Feb 1;16(3):331–344. doi: 10.1016/0024-3205(75)90254-4. [DOI] [PubMed] [Google Scholar]
  8. Cohen G. M., Haws S. M., Moore B. P., Bridges J. W. Benzo(a)pyren-3-yl hydrogen sulphate, a major ethyl acetate-extractable metabolite of benzo(a)pyrene in human, hamster and rat lung cultures. Biochem Pharmacol. 1976 Dec 1;25(23):2561–2570. doi: 10.1016/0006-2952(76)90510-4. [DOI] [PubMed] [Google Scholar]
  9. Cohen G. M., Mehta R., Meredith-Brown M. Large interindividual variations in metabolism of benzo(alpha)pyrene by peripheral lung tissue from lung cancer patients. Int J Cancer. 1979 Aug;24(2):129–133. doi: 10.1002/ijc.2910240202. [DOI] [PubMed] [Google Scholar]
  10. Cohen G. M., Moore B. P. Metabolism of (3H)benzo(a)pyrene by different portions of the respiratory tract. Biochem Pharmacol. 1976 Jul 15;25(14):1623–1629. doi: 10.1016/0006-2952(76)90474-3. [DOI] [PubMed] [Google Scholar]
  11. Cohen G. M., Moore B. P. The metabolism of benzo(a)pyrene, 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene and 9,10-dihydro-9,10-dihydroxybenzono leads to (a)pyrene by short-term organ cultures of hamster lung. Biochem Pharmacol. 1977 Aug 15;26(16):1481–1487. doi: 10.1016/0006-2952(77)90419-1. [DOI] [PubMed] [Google Scholar]
  12. Cohen G. M., Uotila P., Hartiala J., Suolinna E. M., Simberg N., Pelkonen O. Metabolism and covalent binding of [3H]benzo(a)pyrene by isolated perfused lungs and short-term tracheal organ culture of cigarette smoke-exposed rats. Cancer Res. 1977 Jul;37(7 Pt 1):2147–2155. [PubMed] [Google Scholar]
  13. Dees J. H., Masters B. S., Muller-Eberhard U., Johnson E. F. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital on the occurrence and distribution of four cytochrome P-450 isozymes in rabbit kidney, lung, and liver. Cancer Res. 1982 Apr;42(4):1423–1432. [PubMed] [Google Scholar]
  14. Devereux T. R., Hook G. E., Fouts J. R. Foreign compound metabolism by isolated cells from rabbit lung. Drug Metab Dispos. 1979 Mar-Apr;7(2):70–75. [PubMed] [Google Scholar]
  15. Devereux T. R., Serabjit-Singh C. J., Slaughter S. R., Wolf C. R., Philpot R. M., Fouts J. R. Identification of cytochrome P-450 isozymes in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. Exp Lung Res. 1981 Aug;2(3):221–230. doi: 10.3109/01902148109052317. [DOI] [PubMed] [Google Scholar]
  16. Felton J. S., Nebert D. W., Thorgeirsson S. S. Genetic differences in 2-acetylaminofluorene mutagenicity in vitro associated with mouse hepatic aryl hydrocarbon hydroxylase activity induced by polycyclic aromatic compounds. Mol Pharmacol. 1976 Mar;12(2):225–233. [PubMed] [Google Scholar]
  17. Fjellstedt T. A., Allen R. H., Duncan B. K., Jakoby W. B. Enzymatic conjugation of epoxides with glutathione. J Biol Chem. 1973 May 25;248(10):3702–3707. [PubMed] [Google Scholar]
  18. Grover P. L., Hewer A., Pal K., Sims P. The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin. Int J Cancer. 1976 Jul 15;18(1):1–6. doi: 10.1002/ijc.2910180102. [DOI] [PubMed] [Google Scholar]
  19. Grover P. L., Hewer A., Sims P. Formation of K-region epoxides as microsomal metabolites of pyrene and benzo(a)pyrene. Biochem Pharmacol. 1972 Oct 15;21(20):2713–2726. doi: 10.1016/0006-2952(72)90020-2. [DOI] [PubMed] [Google Scholar]
  20. Grover P. L., Hewer A., Sims P. K-region epoxides of polycyclic hydrocarbons: formation and further metabolism of benz (a) anthracene 5,6-oxide by human lung preparations. FEBS Lett. 1973 Aug 1;34(1):63–68. doi: 10.1016/0014-5793(73)80703-3. [DOI] [PubMed] [Google Scholar]
  21. Harris C. C., Autrup H., Connor R., Barrett L. A., McDowell E. M., Trump B. F. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. Science. 1976 Dec 3;194(4269):1067–1069. doi: 10.1126/science.982061. [DOI] [PubMed] [Google Scholar]
  22. Harris C. C., Autrup H., Stoner G., Yang S. K., Leutz J. C., Gelboin H. V., Selkirk J. K., Connor R. J., Barrett L. A., Jones R. T. Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human bronchus and pancreatic duct. Cancer Res. 1977 Sep;37(9):3349–3355. [PubMed] [Google Scholar]
  23. Harris C. C., Genta V. M., Frank A. L., Kaufman D. G., Barrett L. A., McDowell E. M., Trump B. F. Carcinogenic polynuclear hydrocarbons bind to macromolecules in cultured human bronchi. Nature. 1974 Nov 1;252(5478):68–69. doi: 10.1038/252068a0. [DOI] [PubMed] [Google Scholar]
  24. Hirao F., Fujisawa T., Tsubura E., Yamamura Y. Experimental cancer of the lung in rabbits induced by chemical carcinogens. Cancer Res. 1972 Jun;32(6):1209–1217. [PubMed] [Google Scholar]
  25. Hook G. E., Bend J. R., Hoel D., Fouts J. R., Gram T. E. Preparation of lung microsomes and a comparison of the distribution of enzymes between subcellular fractions of rabbit lung and liver. J Pharmacol Exp Ther. 1972 Sep;182(3):474–490. [PubMed] [Google Scholar]
  26. Ioannou Y. M., Wilson A. G., Anderson M. W. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice. Cancer Res. 1982 Apr;42(4):1199–1204. [PubMed] [Google Scholar]
  27. James M. O., Fouts J. R., Bend J. R. Hepatic and extrahepatic metabolism, in vitro, of an epoxide (8-(14) C-styrene oxide) in the rabbit. Biochem Pharmacol. 1976 Jan 15;25(2):187–193. doi: 10.1016/0006-2952(76)90289-6. [DOI] [PubMed] [Google Scholar]
  28. Jeffrey A. M., Weinstein I. B., Jennette K. W., Grzeskowiak K., Nakanishi K., Harvey R. G., Autrup H., Harris C. Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature. 1977 Sep 22;269(5626):348–350. doi: 10.1038/269348a0. [DOI] [PubMed] [Google Scholar]
  29. Jerina D. M., Daly J. W. Arene oxides: a new aspect of drug metabolism. Science. 1974 Aug 16;185(4151):573–582. doi: 10.1126/science.185.4151.573. [DOI] [PubMed] [Google Scholar]
  30. Johnson E. F., Levitt D. S., Muller-Eberhard U., Thorgeirsson S. S. Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450. Cancer Res. 1980 Dec;40(12):4456–4459. [PubMed] [Google Scholar]
  31. Johnson E. F., Muller-Eberhard U. Resolution of two forms of cytochrome P-450 from liver microsomes of rabbit treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem. 1977 May 10;252(9):2839–2845. [PubMed] [Google Scholar]
  32. Kahl G. F., Klaus E., Legraverend C., Nebert D. W., Pelkonen O. Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices. Biochem Pharmacol. 1979 Apr 1;28(7):1051–1056. doi: 10.1016/0006-2952(79)90302-2. [DOI] [PubMed] [Google Scholar]
  33. Lawley P. D. Effects of some chemical mutagens and carcinogens on nucleic acids. Prog Nucleic Acid Res Mol Biol. 1966;5:89–131. doi: 10.1016/s0079-6603(08)60232-9. [DOI] [PubMed] [Google Scholar]
  34. Levin W., Wood A. W., Yagi H., Jerina D. M., Conney A. H. (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo (a)pyrene: a potent skin carcinogen when applied topically to mice. Proc Natl Acad Sci U S A. 1976 Nov;73(11):3867–3871. doi: 10.1073/pnas.73.11.3867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Liem H. H., Muller-Eberhard U., Johnson E. F. Differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin of multiple forms of rabbit microsomal cytochrome P-450: evidence for tissue specificity. Mol Pharmacol. 1980 Nov;18(3):565–570. [PubMed] [Google Scholar]
  36. Marnett L. J., Reed G. A., Johnson J. T. Prostaglandin synthetase dependent benzo(a)pyrene oxidation: products of the oxication and inhibition of their formation by antioxidants. Biochem Biophys Res Commun. 1977 Nov 21;79(2):569–576. doi: 10.1016/0006-291x(77)90195-4. [DOI] [PubMed] [Google Scholar]
  37. Marnett L. J., Reed G. A. Peroxidatic oxidation of benzo[a]pyrene and prostaglandin biosynthesis. Biochemistry. 1979 Jul 10;18(14):2923–2929. doi: 10.1021/bi00581a001. [DOI] [PubMed] [Google Scholar]
  38. Mass M. J., Kaufman D. G. [3H]Benzo(a)pyrene metabolism in tracheal epithelial microsomes and tracheal organ cultures. Cancer Res. 1978 Nov;38(11 Pt 1):3861–3866. [PubMed] [Google Scholar]
  39. Mehta R., Meredith-Brown M., Cohen G. M. Metabolism and covalent binding of benzo[alpha]pyrene in human peripheral lung. Chem Biol Interact. 1979 Dec;28(2-3):345–358. doi: 10.1016/0009-2797(79)90174-1. [DOI] [PubMed] [Google Scholar]
  40. Miyamoto T., Ogino N., Yamamoto S., Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem. 1976 May 10;251(9):2629–2636. [PubMed] [Google Scholar]
  41. Moore B. P., Cohen G. M. Metabolism of benzo(a)pyrene and its major metabolites to ethyl acetate-soluble and water-soluble metabolites by cultured rodent trachea. Cancer Res. 1978 Sep;38(9):3066–3075. [PubMed] [Google Scholar]
  42. Nemoto N., Gelboin H. V. Enzymatic conjugation of benzo (a) pyrene oxides, phenols and dihydrodiols with UDP-glucuronic acid. Biochem Pharmacol. 1976 May 15;25(10):1221–1226. doi: 10.1016/0006-2952(76)90373-7. [DOI] [PubMed] [Google Scholar]
  43. Norman R. L., Muller-Eberhard U., Johnson E. F. The role of cytochrome P-450 forms in 2-aminoanthracene and benz[alpha]pyrene mutagenesis. Biochem Biophys Res Commun. 1979 Jul 12;89(1):195–201. doi: 10.1016/0006-291x(79)90963-x. [DOI] [PubMed] [Google Scholar]
  44. Oesch F. Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica. 1973 May;3(5):305–340. doi: 10.3109/00498257309151525. [DOI] [PubMed] [Google Scholar]
  45. Patel J. M., Harper C., Drew R. T. The biotransformation of p-xylene to a toxic aldehyde. Drug Metab Dispos. 1978 Jul-Aug;6(4):368–374. [PubMed] [Google Scholar]
  46. Patel J. M., Wolf C. R., Philpot R. M. Interaction of 4-methylbenzaldehyde with rabbit pulmonary cytochrome P-450 in the intact animal, microsomes, and purified systems. Destructive and protective reactions. Biochem Pharmacol. 1979 Jul 1;28(13):2031–2036. doi: 10.1016/0006-2952(79)90220-x. [DOI] [PubMed] [Google Scholar]
  47. Prough R. A., Sípal Z., Jakobsson S. W. Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci. 1977 Dec 1;21(11):1629–1635. doi: 10.1016/0024-3205(77)90241-7. [DOI] [PubMed] [Google Scholar]
  48. Robertson I. G., Serabjit-Singh C., Croft J. E., Philpot R. M. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Mol Pharmacol. 1983 Jul;24(1):156–162. [PubMed] [Google Scholar]
  49. Robertson L. G., Philpot R. M., Zeiger E., Wolf C. R. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1. Mol Pharmacol. 1981 Nov;20(3):662–668. [PubMed] [Google Scholar]
  50. Schreiber H., Nettesheim P., Martin D. H. Rapid development of bronchiolo-alveolar squamous cell tumors in rats after intratracheal injection of 3-methylcholanthrene. J Natl Cancer Inst. 1972 Aug;49(2):541–554. [PubMed] [Google Scholar]
  51. Selkirk J. K., Croy R. G., Gelboin H. V. Isolation by high pressure liquid chromatography and characterization of benzo(a)pyrene-4'5-epoxide as a metobolite of benzoapyrene. Arch Biochem Biophys. 1975 May;168(1):322–326. doi: 10.1016/0003-9861(75)90256-8. [DOI] [PubMed] [Google Scholar]
  52. Serabjit-Singh C. J., Wolf C. R., Philpot R. M., Plopper C. G. Cytochrome p-450: localization in rabbit lung. Science. 1980 Mar 28;207(4438):1469–1470. doi: 10.1126/science.6767272. [DOI] [PubMed] [Google Scholar]
  53. Serabjit-Singh C. J., Wolf C. R., Philpot R. M. The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J Biol Chem. 1979 Oct 10;254(19):9901–9907. [PubMed] [Google Scholar]
  54. Simberg N., Uotila P. Stimulatory effect of cigarette smoke on the metabolism and covalent binding of benzo(a)pyrene in the trachea of the rat. Int J Cancer. 1978 Jul 15;22(1):28–31. doi: 10.1002/ijc.2910220107. [DOI] [PubMed] [Google Scholar]
  55. Sims P., Grover P. L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature. 1974 Nov 22;252(5481):326–328. doi: 10.1038/252326a0. [DOI] [PubMed] [Google Scholar]
  56. Sivarajah K., Anderson M. W., Eling T. E. Metabolism of benzo(a)pyrene to reactive intermediate(s) via prostaglandin biosynthesis. Life Sci. 1978 Dec 25;23(26):2571–2578. doi: 10.1016/0024-3205(78)90372-7. [DOI] [PubMed] [Google Scholar]
  57. Sivarajah K., Lasker J. M., Eling T. E. Prostaglandin synthetase-dependent cooxidation of (+/-)-benzo(a)pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res. 1981 May;41(5):1834–1839. [PubMed] [Google Scholar]
  58. Sivarajah K., Mukhtar H., Eling T. Arachidonic acid-dependent metabolism of (+/-) trans-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene (BP-7,8 DIOL) to 7,10/8,9 tetrols. FEBS Lett. 1979 Oct 1;106(1):17–20. doi: 10.1016/0014-5793(79)80685-7. [DOI] [PubMed] [Google Scholar]
  59. Slaga T. J., Bracken W. M., Viaje A., Levin W., Yagi H., Jerina D. M., Conney A. H. Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides. Cancer Res. 1977 Nov;37(11):4130–4133. [PubMed] [Google Scholar]
  60. Slaughter S. R., Statham C. N., Philpot R. M., Boyd M. R. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system. J Pharmacol Exp Ther. 1983 Jan;224(1):252–257. [PubMed] [Google Scholar]
  61. Slaughter S. R., Wolf C. R., Marciniszyn J. P., Philpot R. M. The rabbit pulmonary monooxygenase system. partial structural characterization of the cytochrome P-450 components and comparison to the hepatic cytochrome P-450. J Biol Chem. 1981 Mar 10;256(5):2499–2503. [PubMed] [Google Scholar]
  62. Stoner G. D., Harris C. C., Autrup H., Trump B. F., Kingsbury E. W., Myers G. A. Explant culture of human peripheral lung. I. Metabolism of benzo[alpha]pyrene. Lab Invest. 1978 Jun;38(6):685–692. [PubMed] [Google Scholar]
  63. Ueng T. H., Alvares A. P. Pulmonary cytochromes P-450 from rabbits treated with 3-methylcholanthrene. Mol Pharmacol. 1982 Jul;22(1):221–228. [PubMed] [Google Scholar]
  64. Ueng T. H., Alvares A. P. Selective loss of pulmonary cytochrome P-450I in rabbits pretreated with polychlorinated biphenyls. J Biol Chem. 1981 Jul 25;256(14):7536–7542. [PubMed] [Google Scholar]
  65. Welch R. M., Cavallito J., Loh A. Effect of exposure to cigarette smoke on the metabolism of benzo(a)pyrene and acetophenetidin by lung and intestine of rats. Toxicol Appl Pharmacol. 1972 Dec;23(4):749–758. doi: 10.1016/0041-008x(72)90116-0. [DOI] [PubMed] [Google Scholar]
  66. Welch R. M., Loh A., Conney A. H. Cigarette smoke: stimulatory effect of metabolism of 3,4--benzpyrene by enzymes in rat lung. Life Sci I. 1971 Feb 15;10(4):215–221. doi: 10.1016/0024-3205(71)90250-5. [DOI] [PubMed] [Google Scholar]
  67. Wolf C. R., Slaughter S. R., Marciniszyn J. P., Philpot R. M. Purification and structural comparison of pulmonary and hepatic cytochrome P-450 from rabbits. Biochim Biophys Acta. 1980 Aug 21;624(2):409–419. doi: 10.1016/0005-2795(80)90082-3. [DOI] [PubMed] [Google Scholar]
  68. Wolf C. R., Statham C. N., McMenamin M. G., Bend J. R., Boyd M. R., Philpot R. M. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol. Mol Pharmacol. 1982 Nov;22(3):738–744. [PubMed] [Google Scholar]
  69. Wolf C. R., Szutowski M. M., Ball L. M., Philpot R. M. The rabbit pulmonary monooxygenase system: characteristics and activities of two forms of pulmonary cytochrome P-450. Chem Biol Interact. 1978 Apr;21(1):29–43. doi: 10.1016/0009-2797(78)90066-2. [DOI] [PubMed] [Google Scholar]
  70. Yang S. K., Gelboin H. V., Trump B. F., Autrup H., Harris C. C. Metabolic activation of benzo(a)pyrene and binding to DNA in cultured human bronchus. Cancer Res. 1977 Apr;37(4):1210–1215. [PubMed] [Google Scholar]
  71. van der Hoeven T. A., Haugen D. A., Coon M. J. Cytochrome P-450 purified to apparent homogeneity from phenobarbital-induced rabbit liver microsomes: catalytic activity and other properties. Biochem Biophys Res Commun. 1974 Sep 23;60(2):569–575. doi: 10.1016/0006-291x(74)90278-2. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES